Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 14


Francisella tularensis LVS surface and membrane proteins as targets of effective post-exposure immunization for tularemia.

Chandler JC, Sutherland MD, Harton MR, Molins CR, Anderson RV, Heaslip DG, Bosio CM, Belisle JT.

J Proteome Res. 2015 Feb 6;14(2):664-75. doi: 10.1021/pr500628k. Epub 2014 Dec 29.


Control of intracellular Francisella tularensis by different cell types and the role of nitric oxide.

Newstead SL, Gates AJ, Hartley MG, Rowland CA, Williamson ED, Lukaszewski RA.

J Immunol Res. 2014;2014:694717. doi: 10.1155/2014/694717. Epub 2014 Jul 21.


Monocyte/macrophage inflammatory response pathways to combat Francisella infection: possible therapeutic targets?

Gillette DD, Tridandapani S, Butchar JP.

Front Cell Infect Microbiol. 2014 Feb 21;4:18. doi: 10.3389/fcimb.2014.00018. eCollection 2014. Review.


Immunotherapy for tularemia.

Skyberg JA.

Virulence. 2013 Nov 15;4(8):859-70. doi: 10.4161/viru.25454. Epub 2013 Jun 19. Review.


Lipids derived from virulent Francisella tularensis broadly inhibit pulmonary inflammation via toll-like receptor 2 and peroxisome proliferator-activated receptor α.

Crane DD, Ireland R, Alinger JB, Small P, Bosio CM.

Clin Vaccine Immunol. 2013 Oct;20(10):1531-40. doi: 10.1128/CVI.00319-13. Epub 2013 Aug 7.


Francisella tularensis SchuS4 and SchuS4 lipids inhibit IL-12p40 in primary human dendritic cells by inhibition of IRF1 and IRF8.

Ireland R, Wang R, Alinger JB, Small P, Bosio CM.

J Immunol. 2013 Aug 1;191(3):1276-86. doi: 10.4049/jimmunol.1300867. Epub 2013 Jul 1.


The stimulated innate resistance event in Bordetella pertussis infection is dependent on reactive oxygen species production.

Zurita E, Moreno G, Errea A, Ormazabal M, Rumbo M, Hozbor D.

Infect Immun. 2013 Jul;81(7):2371-8. doi: 10.1128/IAI.00336-13. Epub 2013 Apr 29.


B1a cells enhance susceptibility to infection with virulent Francisella tularensis via modulation of NK/NKT cell responses.

Crane DD, Griffin AJ, Wehrly TD, Bosio CM.

J Immunol. 2013 Mar 15;190(6):2756-66. doi: 10.4049/jimmunol.1202697. Epub 2013 Feb 1.


Post-exposure immunization against Francisella tularensis membrane proteins augments protective efficacy of gentamicin in a mouse model of pneumonic tularemia.

Sutherland MD, Goodyear AW, Troyer RM, Chandler JC, Dow SW, Belisle JT.

Vaccine. 2012 Jul 13;30(33):4977-82. doi: 10.1016/j.vaccine.2012.05.037. Epub 2012 May 28.


Nasal Acai polysaccharides potentiate innate immunity to protect against pulmonary Francisella tularensis and Burkholderia pseudomallei Infections.

Skyberg JA, Rollins MF, Holderness JS, Marlenee NL, Schepetkin IA, Goodyear A, Dow SW, Jutila MA, Pascual DW.

PLoS Pathog. 2012;8(3):e1002587. doi: 10.1371/journal.ppat.1002587. Epub 2012 Mar 15.


Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemia.

Crane DD, Scott DP, Bosio CM.

PLoS One. 2012;7(3):e33349. doi: 10.1371/journal.pone.0033349. Epub 2012 Mar 12.


Host-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity.

Zarrella TM, Singh A, Bitsaktsis C, Rahman T, Sahay B, Feustel PJ, Gosselin EJ, Sellati TJ, Hazlett KR.

PLoS One. 2011;6(7):e22335. doi: 10.1371/journal.pone.0022335. Epub 2011 Jul 22.


IFN-β mediates suppression of IL-12p40 in human dendritic cells following infection with virulent Francisella tularensis.

Bauler TJ, Chase JC, Bosio CM.

J Immunol. 2011 Aug 15;187(4):1845-55. doi: 10.4049/jimmunol.1100377. Epub 2011 Jul 13.


The subversion of the immune system by francisella tularensis.

Bosio CM.

Front Microbiol. 2011 Feb 1;2:9. doi: 10.3389/fmicb.2011.00009. eCollection 2011.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk